Multiple-Dose Study Apixaban in Pediatric Subjects With an Indwelling Central Venous Catheter

Stopped early · Phase 1

Conditions studied: Venous Thromboembolism

In brief

CV185-079 is a multiple dose Apixaban Pharmacokinetics/Pharmacodynamics (PK/PD) study in pediatric subjects. The objective of this study is primarily to study the PK/PD of Apixaban in pediatric subjects with a central venous catheter.

Key facts

Study ID
NCT01195727
Run by
Bristol-Myers Squibb
People needed
13
Starts
2011-07-26
Expected to finish
2012-07-16
Last updated by the study team
2017-04-07

Who can join

Age: 12 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.